{"nct_id":"NCT00452673","title":"Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer","status":"COMPLETED","status_verified_date":"2015-03","start_date":"2007-06","start_date_type":null,"primary_completion_date":"2012-10","primary_completion_date_type":"ACTUAL","completion_date":"2012-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}